MXPr, short for Methoxpropamine, is a dissociative research chemical belonging to the arylcyclohexylamine class — the same family as ketamine and PCP. It acts primarily as an NMDA receptor antagonist, leading to a disruption in normal neural communication. This results in altered sensory perception, a detachment from physical reality, and a range of introspective mental states. MXPr is sought for its balance between mild euphoria and dissociative clarity, making it a popular choice for both new and experienced users exploring non-ordinary states of consciousness.

• NMDA Antagonist Mechanism: MXPr works by blocking the NMDA receptor, a crucial receptor in the brain responsible for synaptic plasticity, learning, and memory. Its antagonism leads to reduced sensory integration and promotes dissociative states.

• Moderate Dissociative Effects: Users often report a floating sensation, detachment from the body, and a distorted sense of time. Unlike stronger dissociatives like PCP or 3-MeO-PCP, MXPr tends to maintain a degree of cognitive clarity, even during peak experiences.

• Emotional Neutrality and Euphoria: At moderate doses, many users describe a calm emotional state, sometimes accompanied by a gentle euphoria. It can reduce anxiety and overthinking without causing extreme sedation or mania.

• Altered Visual and Auditory Perception: MXPr can cause closed-eye visuals, changes in sound perception, and dream-like states, especially at higher doses. These effects are typically mild but can become intense in deep dissociative states.

• Cognitive Detachment and Introspection: MXPr facilitates introspective thinking and often brings abstract concepts or internal narratives to the forefront. Many users find it useful for philosophical contemplation.

• Physical Discoordination: Due to its dissociative nature, MXPr can impair motor control and balance. This makes it unsuitable for activities that require coordination or alertness during use.

• Duration and Onset: Effects typically begin within 20–40 minutes when taken orally, or 5–15 minutes intranasally. The experience can last between 3 and 6 hours depending on dose, route, and individual metabolism.

The legal status of MXPr varies significantly across countries and regions. While it remains unscheduled in some jurisdictions, it has been explicitly banned in others. Before purchasing or importing MXPr, it is critical to understand your local and national laws to avoid legal complications. At Psycho Plug, we take your safety and compliance seriously — we ship only to countries where the product is not explicitly restricted.

• Unscheduled in Some Countries: In many parts of the world, MXPr is not listed under controlled substances legislation, allowing for legal sale and purchase for research purposes.

• Explicitly Banned in Select Jurisdictions: Countries such as the United Kingdom, parts of the EU, and some U.S. states have laws that classify MXPr or structurally similar compounds as controlled substances.

• Research Chemical Classification: Even where legal, MXPr is often sold under the condition that it is not intended for human consumption. This research-only designation can impact how it’s handled legally.

• Import and Customs Regulations: Even if legal in your country, customs enforcement can vary. Some customs agencies may confiscate packages containing research chemicals regardless of local legality.

• Responsibility Lies With the Buyer: It is the customer’s responsibility to verify the legality of MXPr in their jurisdiction. We recommend checking with legal resources or local authorities if uncertain.

• Psycho Plug Compliance: We review shipping addresses and country laws to prevent accidental delivery to banned regions. If your country restricts MXPr, we will not ship your order and may suggest legal alternatives.

• Privacy Protection Regardless of Region: Even where legal, we maintain strict confidentiality in packaging and handling to protect your identity and privacy.

We pride ourselves on offering only the highest quality MXPr available on the market. Every batch is sourced from verified laboratories and tested by independent third parties to ensure a purity level of 98% or higher. Our commitment to quality ensures consistency, safety, and satisfaction for our customers.

• ≥98% Laboratory-Tested Purity: Each batch of MXPr is rigorously tested for impurities, contaminants, and verification of the active compound. This guarantees you receive a clean, consistent product every time.

• Third-Party Certification: We use external analytical labs for unbiased testing. Certificates of Analysis (CoA) are available upon request for transparency and verification.

• No Cutting Agents or Fillers: Our MXPr is never mixed or diluted with other substances. It is supplied in its purest form, ready for research or responsible use.

• Batch Consistency: Each batch undergoes quality control procedures to ensure chemical uniformity across all shipped products.

• Secure Packaging for Stability: We use vacuum-sealed, light-resistant packaging to maintain chemical integrity during storage and transit.

• Handling in Controlled Environments: Our facility follows strict environmental protocols to prevent degradation caused by heat, humidity, or cross-contamination.

• Customer Satisfaction Guarantee: If you believe your product is not up to our quality standard, we offer a full refund or replacement policy within 30 days.

Although MXPr and MXE (Methoxetamine) are structurally similar dissociatives, their effects, durations, and legal status differ significantly. MXE was widely used prior to its ban in many countries, and MXPr emerged as an alternative that preserves some of its desirable traits while introducing a smoother, more manageable profile.

• Potency Differences: MXE is typically more potent by weight than MXPr. A smaller amount of MXE is needed to reach equivalent dissociative effects, whereas MXPr offers more subtle gradients of experience across doses.

• Duration of Effects: MXE can last up to 8 hours, while MXPr has a slightly shorter effect profile of 3 to 6 hours. This makes MXPr more manageable for those who want shorter, less disruptive sessions.

• Subjective Experience: MXE is often described as more euphoric and immersive, potentially leading to powerful emotional or spiritual journeys. MXPr, on the other hand, is considered more cerebral and reflective with less emotional volatility.

• Safety and Control: Many users report that MXPr provides more mental clarity and less confusion or mania than MXE, especially at higher doses. This can make MXPr preferable for introspection and low-risk exploration.

• Legal Accessibility: MXE has been classified as a controlled substance in most parts of the world. MXPr is still unscheduled in several regions, making it more widely available and legal to obtain.

• Recreational Risk Profile: MXE was associated with higher incidences of binge use and psychological dependence. MXPr’s lighter effects and shorter duration make it easier to control and less likely to result in overuse.

• Availability and Modern Use: MXPr is commonly sold in online research chemical markets today, while MXE has become rare due to its legal status.

While MXPr is generally considered safer than some dissociatives when used responsibly, it still carries risks — especially with high doses or improper use. Understanding its side effects is essential for harm reduction and safe exploration.

• Cognitive Confusion: Higher doses can lead to disorientation, confusion, and temporary memory lapses. These cognitive impairments are typically short-lived but can be intense during peak effects.

• Loss of Coordination and Motor Function: MXPr can severely impair balance, fine motor skills, and spatial awareness. Accidents can occur if one attempts to move around while under its influence.

• Nausea and Dizziness: Some users report nausea during onset or at high doses, especially when using MXPr intranasally. Remaining still during the peak often reduces discomfort.

• Psychological Disturbance: In rare cases, especially with high or repeated use, MXPr may trigger anxiety, paranoia, or depersonalization. A calm, safe setting greatly reduces these risks.

• Bladder and Urinary Health: Although no long-term data exists on MXPr, similar compounds like ketamine have been linked to urinary tract issues with heavy or chronic use. Long-term daily use is discouraged.

• Rapid Tolerance Development: MXPr builds tolerance quickly. Taking it too often may lead to diminished effects and encourage redosing, which increases the risk of unintended high doses.

• Interaction Dangers: Mixing MXPr with alcohol, benzodiazepines, opioids, or other depressants can suppress breathing and dramatically increase danger. It should always be used alone unless interactions are well understood.

• Mental Health Considerations: Individuals with a history of psychosis, schizophrenia, or dissociative disorders should avoid MXPr, as it may exacerbate underlying conditions.

MXPr dosage varies significantly depending on the route of administration, individual body weight, metabolism, prior experience with dissociatives, and the desired depth of effect. It is crucial to use precise measurement tools (like a milligram scale) and start with the lowest effective dose, especially for beginners. MXPr is a potent substance, and its effects can become overwhelming at higher doses. While it is typically used orally or intranasally, each route has its own onset and intensity profile.

• Threshold Dose (Oral/Nasal): A threshold dose is the minimum amount required to feel any noticeable effect. For MXPr, this is generally around 5–10 mg orally, or 3–5 mg intranasally. At this range, you may feel mild mental fog, light body sensations, or subtle shifts in perception.

• Light Dose: A light dose provides gentle dissociation without loss of motor control. Oral users usually consume 10–20 mg, while intranasal users report 5–15 mg. This level may enhance introspection and cause mild time distortion.

• Common/Moderate Dose: This is the most frequently used range for MXPr and is where its dissociative qualities become more pronounced. Doses of 20–35 mg orally or 10–25 mg nasally typically lead to body detachment, a floating sensation, and reduced emotional reactivity.

• Strong Dose: For deep dissociation or near out-of-body experiences, users may take 35–50 mg orally or 25–40 mg intranasally. At this point, the experience may become immersive and difficult to navigate without prior experience or a controlled environment.

• Route Sensitivity: Intranasal use brings faster onset and higher intensity, but often shorter duration. Oral dosing is slower but smoother and longer-lasting. Sublingual use has milder effects and is not commonly preferred.

• Re-dosing Risks: Re-dosing can significantly increase the duration and intensity of effects and should be done cautiously. Overlapping doses may lead to unexpected or overwhelming experiences.

• Use a Precision Scale: MXPr is active in the milligram range. Never eyeball your dose — a precision scale accurate to at least 0.001g is essential.

MXPr, like many research chemicals, is chemically sensitive to environmental factors such as heat, moisture, and UV light. Improper storage can lead to degradation, loss of potency, and contamination over time. Preserving its stability is essential to ensure safety, consistency, and reliability for future use.

• Cool and Dry Environment: Always store MXPr in a location that remains cool and dry. Exposure to heat and humidity can break down the compound’s chemical structure, reducing effectiveness.

• Airtight Containers: Use vacuum-sealed or airtight glass vials with a secure lid. This prevents oxygen and airborne moisture from affecting the substance and helps protect it from environmental degradation.

• Avoid UV Exposure: Light, particularly UV light, can degrade MXPr over time. Always store it in opaque or amber-colored containers or in a dark cabinet or drawer.

• Label Clearly and Accurately: Always mark your storage container with the substance name, purity (if known), and the date of purchase or packaging. This avoids confusion and helps track chemical shelf life.

• Long-Term Storage Options: For long-term storage (several months or longer), some users store MXPr in the freezer (well-sealed, airtight, and double-bagged to prevent condensation). Allow it to reach room temperature before unsealing to avoid moisture condensation.

• Avoid Frequent Opening: Each time the container is opened, it introduces oxygen and humidity. Minimize exposure by dividing doses in advance and using separate smaller containers when possible.

• Keep Out of Reach: Store MXPr out of reach of children, pets, or anyone not authorized to handle research chemicals. This prevents accidental ingestion and ensures safe handling.

The duration of MXPr’s subjective effects is typically between 3 and 6 hours, but traces of the compound may remain detectable in the body longer depending on dosage, metabolism, and the method of ingestion. Although not commonly tested in standard drug screenings, it’s important to understand its metabolic profile if timing is important for work, medical appointments, or legal reasons.

• Duration of Effects: Most users experience effects for 3 to 6 hours, depending on the dose and route. Oral use tends to last longer, while intranasal use is more intense but shorter in duration.

• Onset and Peak: Oral onset begins at 20–40 minutes, peaking around 90 minutes and gradually tapering off over several hours. Nasal onset is faster (5–15 minutes) but typically results in a sharper peak and shorter plateau.

• Half-Life Estimates: While detailed pharmacokinetic data on MXPr is limited, user reports suggest a half-life of approximately 3 to 5 hours, meaning the substance is likely cleared significantly from the bloodstream within 12–24 hours.

• Detectability in Urine: MXPr may be detectable in urine for up to 1–2 days following use, depending on dosage and individual metabolism. However, this can vary and is not confirmed by formal studies.

• Standard Drug Tests: MXPr is generally not included in standard 5- or 10-panel drug tests. Specialized testing would be required to detect it, which is rare outside of forensic or toxicology settings.

• Metabolic Clearance: MXPr is believed to be primarily metabolized in the liver and excreted via the kidneys. Hydration and a healthy metabolism may influence clearance rates.

• Fatigue and Aftereffects: Some users report feeling slightly foggy or tired the day after a strong MXPr session. These aftereffects are typically short-lived and resolve with rest.

Combining MXPr with other substances can significantly alter its effects, both in terms of intensity and safety. While some users experiment with combinations (also known as “stacking” or “cocktails”), these mixtures can be unpredictable and potentially hazardous. Great caution and informed planning are critical when considering any form of poly-drug use involving MXPr.

• Avoid Alcohol: Combining MXPr with alcohol can suppress respiration, increase nausea, and impair motor function more severely. The mixture is considered dangerous and increases the risk of accidents or unconsciousness.

• Do Not Mix with Benzodiazepines or Opioids: These central nervous system depressants can enhance sedation and respiratory depression, leading to life-threatening consequences when mixed with dissociatives like MXPr.

• Stimulant Interaction Risks: Combining MXPr with stimulants (such as amphetamines or cocaine) can lead to cardiovascular stress, increased anxiety, and paranoia. The mixture is erratic and strongly discouraged.

• Cannabis Synergy: Some users report enhanced visuals and body sensation when combining MXPr with cannabis. However, it can also amplify confusion or anxiety, especially at high doses or in unfamiliar settings.

• Psychedelics (LSD, Psilocybin): Combining MXPr with classic psychedelics can create deeply immersive and disorienting experiences. While some explore this mix for spiritual reasons, it’s highly unpredictable and can lead to emotional overwhelm.

• SSRIs or MAOIs: There is limited research on interactions between MXPr and prescription antidepressants. Due to unknown metabolic pathways, this combination should be avoided unless medically supervised.

• Safer Practices: If combining MXPr with any substance, ensure it’s done in a safe, controlled environment, with someone sober present, and never without prior research into the potential interaction risks.

MXPr produces a wide array of psychological and sensory effects depending on dosage, setting, and user experience. It is considered a moderate-intensity dissociative, offering a balance between physical detachment, cognitive introspection, and mild visual alterations. Unlike stronger dissociatives that can cause overwhelming dissociation or manic episodes, MXPr is often described as “clean,” “manageable,” or “lucid.”

• Dissociation from the Body: Users report a floating sensation, often accompanied by physical numbness and a lack of proprioception — meaning they can no longer sense where their limbs are or how their body is positioned in space.

• Cognitive Detachment: MXPr induces a shift in thought patterns, often described as mentally “stepping back” from one’s normal stream of consciousness. This can feel meditative, philosophical, or dream-like.

• Altered Time Perception: Time often feels warped. Minutes may feel like hours, or vice versa, depending on the intensity of the experience. This effect can be both calming or disorienting.

• Emotional Blunting: Many users experience emotional neutrality — an indifference to stimuli that would normally provoke strong emotional responses. This effect is commonly sought for reflection or emotional decompression.

• Visual and Auditory Distortion: MXPr may produce closed-eye visuals, auditory flanging, light trails, or shifting shadows. While not as visually intense as psychedelics, these distortions contribute to its dream-like quality.

• Inner Narrative Amplification: MXPr can heighten internal dialogue and provoke vivid mental images, memories, or symbolic thought chains. Some users describe this as spiritual or self-revealing.

• Physical Discoordination: Motor control is often compromised. Walking or standing may be difficult, especially at higher doses. Many prefer to remain seated or lying down throughout the experience.

• Post-Session Afterglow: After effects often include a calm state of mind, residual introspection, and light fatigue. This “afterglow” may last several hours and is generally considered pleasant.

While MXPr does not typically cause physical dependence like opioids or stimulants, it can lead to psychological habituation, especially when used frequently or at high doses. As with other dissociatives, the pleasant detachment and introspection it offers may encourage overuse, particularly among users seeking escape from emotional discomfort or boredom. Responsible, spaced-out use significantly reduces the risk of dependency.

• Rapid Tolerance Build-Up: MXPr induces tolerance quickly. After just one or two sessions, users may find that the same dose has diminished effects. This encourages redosing or escalating dosages, both of which increase the risk of psychological dependency.

• No Known Physical Withdrawal: Unlike substances such as benzodiazepines or alcohol, MXPr does not appear to cause physical withdrawal symptoms. Users do not report body aches, tremors, or other signs of acute withdrawal upon cessation.

• Compulsive Use Potential: Although less addictive than stronger dissociatives like PCP, MXPr can still be used compulsively. Individuals prone to addictive behaviors may find themselves using MXPr more frequently than intended.

• Escapism and Emotional Detachment: The sense of emotional neutrality and mental distance provided by MXPr may become a psychological crutch for users dealing with anxiety, depression, or trauma, increasing the risk of emotional dependency.

• Mental Fatigue and Cognitive Blunting: Frequent use may impair short-term memory, decision-making, and emotional processing. These lingering effects, while subtle, can accumulate over time if MXPr is used repeatedly.

• Safe Use Guidelines: The best way to avoid dependency is to use MXPr infrequently, ideally with at least two weeks between sessions, and only in meaningful, well-planned contexts rather than as a habitual escape.

• Set a Usage Schedule: Some users create a usage journal or limit their sessions to special occasions, helping avoid unconscious overuse and maintaining the compound’s therapeutic potential without dependence.

MXPr and ketamine are both dissociative anesthetics from the arylcyclohexylamine family, but their effects, duration, medical use, and legal status differ considerably. While ketamine is an FDA-approved medication for anesthesia and treatment-resistant depression, MXPr is a research chemical intended for non-medical exploratory purposes. Understanding their distinctions is vital for choosing the appropriate compound based on intent, context, and safety.

• Medical vs. Research Use: Ketamine is used clinically for anesthesia and mental health treatments, particularly in controlled, therapeutic settings. MXPr is not approved for medical use and is instead studied for its psychoactive properties in non-clinical contexts.

• Onset and Duration: Ketamine has a rapid onset (especially when injected or snorted) and a short duration, typically 1–2 hours. MXPr has a slower onset and a longer duration of 3–6 hours, providing a more extended window for introspection or sensory exploration.

• Subjective Effects: MXPr is described as less sedating and more introspective than ketamine. It tends to maintain mental clarity longer, while ketamine can produce stronger dissociation, body anesthesia, and vivid internal hallucinations at higher doses.

• Dose Sensitivity: Ketamine is active at very low doses (under 50 mg), especially via injection, and is often unpredictable in uncontrolled environments. MXPr has a wider effective range, and its slower onset may make dosing more forgiving.

• Legal Status: Ketamine is classified as a Schedule III substance in the U.S. and controlled in many other countries. MXPr is unscheduled in several regions, making it easier to obtain for research but not approved for medical or therapeutic use.

• Bladder Health Considerations: Both substances may impact bladder health with chronic high-dose use, but ketamine is more strongly associated with ketamine bladder syndrome, a painful and potentially permanent condition. MXPr has not been studied as extensively but should still be used cautiously in this regard.

• Therapeutic Exploration: While ketamine is used in clinical psychiatry, MXPr is explored by some users in self-reflective or ritualistic settings. However, any therapeutic benefits from MXPr remain anecdotal and unverified in formal studies.

MXPr is not an approved therapeutic agent and should not be used as a substitute for medical treatment. However, some individuals report personal or introspective breakthroughs during MXPr experiences that they consider therapeutic. These may include emotional processing, philosophical insight, or confronting suppressed thoughts. While these experiences can be meaningful, they should not be confused with evidence-based therapy.

• No Clinical Research Backing: MXPr has not undergone controlled clinical studies to evaluate its safety or efficacy for treating mental health disorders. Any therapeutic claims are anecdotal and lack empirical support.

• Potential for Emotional Insight: Some users describe MXPr as facilitating a state where they can examine painful memories, reframe thought patterns, or experience catharsis. This is especially reported during low to moderate doses in calm settings.

• Emotional Detachment Can Be Beneficial: MXPr’s blunting of emotional intensity may help users view emotionally charged situations with more objectivity, similar to the way some therapists encourage cognitive distancing.

• Enhanced Introspection: The dissociative state may create space between one’s thoughts and self-identity, making it easier to observe patterns and triggers without emotional reactivity.

• Risks of Misuse: Self-medicating with MXPr can lead to avoidance rather than resolution. It may provide temporary relief but does not replace structured therapy, support systems, or clinical treatment plans.

• Lack of Integration Support: Unlike psychedelic therapy sessions which include preparation and integration, MXPr sessions are often conducted solo without guidance, which may reduce the potential for lasting therapeutic benefit.

• Not a Substitute for Professional Help: Those experiencing mental illness should consult a licensed therapist or psychiatrist, rather than relying on dissociatives for emotional relief.

MXPr can be suitable for first-time users of dissociatives if approached with caution, preparation, and proper dosing. It is often described as more gentle and forgiving than more potent compounds like 3-MeO-PCP or ketamine, especially in its ability to maintain a degree of cognitive clarity at moderate doses. That said, any dissociative experience can be overwhelming if not used responsibly.

• Lower Potency Profile: MXPr’s moderate potency makes it more manageable for newcomers. It offers clear effects without the intense body load or sedation seen in stronger compounds, reducing the risk of panic or confusion.

• Gradual Onset Allows Adjustment: The slower onset of MXPr (especially when taken orally) allows users to acclimate to the effects more gradually, minimizing the chance of abrupt psychological shifts.

• Cognitive Clarity at Moderate Doses: Unlike some dissociatives that cause severe disorientation even at light doses, MXPr preserves a degree of lucidity, which is helpful for those unfamiliar with non-ordinary states.

• Easy to Titrate: MXPr is active in the 10–40 mg range, which allows for fine-tuned dosing. First-time users can start at the lower end and titrate up safely if desired.

• Safer with Sober Supervision: Having a trusted friend or “trip sitter” nearby ensures safety in case of unexpected effects, especially for first-time users unfamiliar with dissociative experiences.

• Avoid Complex Environments: New users should start in a quiet, familiar, and comfortable setting, free from distractions or emotional stressors, to reduce the chance of a negative experience.

• Must Use a Milligram Scale: First-time users must understand the critical importance of accurate dosing. Using a scale that measures to 0.001g ensures safety and consistency, especially with low doses.

MXPr is not classified as a classical hallucinogen like LSD or psilocybin, but it can produce perceptual distortions and internal hallucinations, especially at higher doses. The effects are primarily dissociative rather than psychedelic, meaning they involve changes in body perception, sensory processing, and mental space rather than vivid, externally directed visuals. Still, some users report mild to moderate hallucinations under certain conditions.

• Closed-Eye Visuals (CEVs): Users frequently report seeing patterns, flashes of light, or shifting imagery with their eyes closed. These visuals tend to be subtle but become more immersive at higher doses.

• Auditory Flanging and Echoes: Sounds may become distorted, stretched, or echoed. These effects are part of the dissociative experience and not true auditory hallucinations.

• Time and Space Warping: MXPr can distort the perception of time and depth, making environments feel unfamiliar or unreal — a form of perceptual hallucination.

• Phantom Sensations: Some users experience tactile hallucinations, such as feeling vibrations, warmth, or presence in parts of the body that aren’t stimulated. This may also include sensations of floating or sinking.

• Internal Hallucinations: In higher doses or with eyes closed, users may enter vivid mental “scenes” or dream-like experiences. These internal hallucinations may be symbolic, abstract, or narrative-driven.

• Low Hallucinogenic Risk at Light Doses: At doses below 20 mg, hallucinations are rare. Most users report a clearer and more grounded headspace, especially in well-lit or familiar environments.

• Set and Setting Influence: Hallucinatory effects can be amplified in dark or silent environments, or when mixed with other substances such as cannabis or psychedelics. MXPr alone is unlikely to produce open-eye hallucinations under normal conditions.